Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Doranidazole

Home DrugsDoranidazole

Investigational

Small Molecule

Doranidazole

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₈H₁₃N₃O₆
CAS Number: 149838-23-3
UNII ID: 911XR034RX

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Radiotherapy combined with hypoxic cell sensitizers
US 9393439 B2Applicant: GOER DONALD ALLENPriority: 2011
CN
US
4 publications
Method for synthesizing diastereoisomer of Doranidazole intermediate
CN 101805323 BApplicant: SHENZHEN MAIN LUCK PHARMACEUTICALS INCPriority: 2010
CN